The incorporation of multiple antigens into a single human papillomavirus (HPV) vaccine may induce immune interference. To evaluate whether interference occurs when HPV type 16 (HPV16) virus-like particles are combined in a multivalent vaccine, we conducted a study to evaluate anti-HPV16 responses among subjects receiving three-dose regimens of either a monovalent HPV16 vaccine or a quadrivalent HPV (types 6, 11, 16, and 18) vaccine. Copyright © 2007, American Society for Microbiology. All Rights Reserved.link_to_subscribed_fulltex
Background: A prophylactic human papillomavirus (HPV) vaccine targeting oncogenic HPV types in addit...
Aim of this investigator-initiated study was to evaluate and compare the titres of neutralizing and ...
In order to assess HPV-specific IgG characteristics, we evaluated multiple aspects of the humoral an...
ABSTRACT 23 Numerous versions of human papillomavirus (HPV) therapeutic vaccines designed to treat 2...
AbstractChimeric human papillomavirus virus-like particles (HPV cVLPs) carrying HPV16 E7 protein are...
Cervical cancer results from cervical infection by human papillomaviruses (HPV), especially HPV16. P...
Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV1...
The efficacy of the quadrivalent Human Papillomavirus (HPV) vaccine is thought to be mediated by hum...
Persistent infection with human papillomavirus (HPV) is a key factor in the development of precancer...
AbstractHuman papillomavirus-like particles (HPV VLP) are candidate vaccines that have shown to be e...
The current generation of Human Papillomavirus (HPV) vaccines, Cervarix® and Gardasil®, exhibit a hi...
Human papillomavirus (HPV) infection causes cervical cancer and genital warts. Young women (1106) we...
Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV1...
Detection of genotype-specific human papillomavirus (HPV) capsid antibody in serum suggests past HPV...
AbstractThe highly efficacious human papillomavirus (HPV) vaccines contain virus-like particles (VLP...
Background: A prophylactic human papillomavirus (HPV) vaccine targeting oncogenic HPV types in addit...
Aim of this investigator-initiated study was to evaluate and compare the titres of neutralizing and ...
In order to assess HPV-specific IgG characteristics, we evaluated multiple aspects of the humoral an...
ABSTRACT 23 Numerous versions of human papillomavirus (HPV) therapeutic vaccines designed to treat 2...
AbstractChimeric human papillomavirus virus-like particles (HPV cVLPs) carrying HPV16 E7 protein are...
Cervical cancer results from cervical infection by human papillomaviruses (HPV), especially HPV16. P...
Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV1...
The efficacy of the quadrivalent Human Papillomavirus (HPV) vaccine is thought to be mediated by hum...
Persistent infection with human papillomavirus (HPV) is a key factor in the development of precancer...
AbstractHuman papillomavirus-like particles (HPV VLP) are candidate vaccines that have shown to be e...
The current generation of Human Papillomavirus (HPV) vaccines, Cervarix® and Gardasil®, exhibit a hi...
Human papillomavirus (HPV) infection causes cervical cancer and genital warts. Young women (1106) we...
Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV1...
Detection of genotype-specific human papillomavirus (HPV) capsid antibody in serum suggests past HPV...
AbstractThe highly efficacious human papillomavirus (HPV) vaccines contain virus-like particles (VLP...
Background: A prophylactic human papillomavirus (HPV) vaccine targeting oncogenic HPV types in addit...
Aim of this investigator-initiated study was to evaluate and compare the titres of neutralizing and ...
In order to assess HPV-specific IgG characteristics, we evaluated multiple aspects of the humoral an...